Concepedia

Léa Hoisnard

LH

Statistics

Publications

13

Citations

561

H-Index

11

Active since

2018

Affiliations

Assistance Publique – Hôpitaux de Paris(Current)

Université Paris-Est Créteil

Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail

Epidemiology in dermatology and evaluation of therapeutics

Léa Hoisnard is an author at Assistance Publique – Hôpitaux de Paris specializing in pharmacotherapy, clinical pharmacology, and pharmacy.

Publications per year

2018–2024

13

Publications

13

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

Léa Hoisnard, Bénédicte Lebrun‐Vignes, Sébastien Maury et al. · Scientific Reports · 2022 · 171 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study

Léa Hoisnard, Laura Pina Vegas, Rosemary Dray‐Spira et al. · Annals of the Rheumatic Diseases · 2022 · 118 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Use of progestogens and the risk of intracranial meningioma: national case-control study

Noémie Roland, Anke Neumann, Léa Hoisnard et al. · BMJ · 2024 · 67 citations · Full text

Veterinary Medicine, Endocrinology, Reproductive Endocrinology +9

Risk of intracranial meningioma with three potent progestogens: A population‐based case–control study

Léa Hoisnard, Moussa Laanani, Thibault Passeri et al. · European Journal of Neurology · 2022 · 61 citations · Full text

Medicine, Neurosurgery, Neuroendocrinology +9

Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies

Philipp Gauckler, Anna Matyjek, Eleni Kapsia et al. · Journal of the American Society of Nephrology · 2024 · 28 citations · Full text

Medicine, Immunology, Nephrology +16

1–5 of 13